A Phase I Dose Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacokinetics and Neuropharmacodynamics of Temsirolimus With and Without Temozolomide in Patients With Primary or Metastatic Brain Tumors.
Phase of Trial: Phase I
Latest Information Update: 28 Jul 2016
At a glance
- Drugs Temsirolimus (Primary) ; Temozolomide
- Indications Brain cancer; Cancer metastases; Solid tumours
- Focus Adverse reactions; Pharmacodynamics
- 09 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Nov 2008 New trial record.